<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-61732</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Consensus Document for the Treatment of Bacteremia and Endicarditis Caused by Methicillin-Resistent Staphylococcus Aureus</dc:title>
<dc:description xml:lang="en">Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA) are prevalent and clinically important. The rise in MRSA bacteremia and endocarditis is related with the increasing use of venous catheters and other vascular procedures. Glycopeptides have been the reference drugs for treating these infections. Unfortunately their activity is not completely satisfactory, particularly against MRSA strains with  (..) (AU)</dc:description>
<dc:creator>Miró, José María</dc:creator>
<dc:creator>Rodríguez-Baño, Jesús</dc:creator>
<dc:creator>Vallés, Jordi</dc:creator>
<dc:creator>Soriano, Álex</dc:creator>
<dc:creator>Tornos, Pilar</dc:creator>
<dc:creator>Domínguez, María de los Ángeles</dc:creator>
<dc:creator>Pujol, Miquel</dc:creator>
<dc:creator>Cercenado, Emilia</dc:creator>
<dc:creator>Almirante, Benito</dc:creator>
<dc:creator>Bouza, Emilio</dc:creator>
<dc:creator>Gudiol, Francisco</dc:creator>
<dc:creator>Palomar, Mercedes</dc:creator>
<dc:creator>Pascual, Álvaro</dc:creator>
<dc:creator>Aguado, José María</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La relevancia clínica de la bacteriemia y de la endocarditis por Staphylococcus aureus resistente a la meticilina (SARM) es enorme. El incremento en la incidencia de bacteriemia y endocarditis por SARM está en relación con el uso creciente de catéteres y la realización de manipulaciones vasculares. Los antibióticos glucopéptidos han sido los fármacos de referencia para el tratamiento de estas infecciones, pero desgraciadamente su actividad no es del todo satisfactoria, especialmente frente a cepas de SARM con CMI a la vancomicina (..) (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;27(2): 105-115, feb. 2009. tab</dc:source>
<dc:identifier>ibc-61732</dc:identifier>
<dc:title xml:lang="es">Documento de consenso sobre el tratamiento de la bacteriemia y la endocarditis causada por Staphylococcus aureus resistente a la meticilina</dc:title>
<dc:subject>^d4778^s22057</dc:subject>
<dc:subject>^d8889^s22078</dc:subject>
<dc:subject>^d23183^s22020</dc:subject>
<dc:subject>^d29627</dc:subject>
<dc:subject>^d4778^s22016</dc:subject>
<dc:subject>^d4778^s22027</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30241^s22057</dc:subject>
<dc:subject>^d22165</dc:subject>
<dc:subject>^d30241^s22016</dc:subject>
<dc:subject>^d30241^s22027</dc:subject>
<dc:subject>^d34573</dc:subject>
<dc:type>article</dc:type>
<dc:date>200902</dc:date>
</metadata>
</record>
</ibecs-document>
